Загрузка...
Risks associated with tiotropium in chronic obstructive pulmonary disease: overview of the evidence to date
Tiotropium is a long-acting inhaled anticholinergic agent that is widely used in the treatment of chronic obstructive pulmonary disease (COPD). It was initially launched as the tiotropium HandiHaler formulation, but this was followed by a newer version based on a potentially more efficient drug deli...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4110823/ https://ncbi.nlm.nih.gov/pubmed/25083231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098612438388 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|